Neogen Chemicals Limited — Important, 12-11-2024: General Updates

**Financial Highlights:**

For the quarter ended September 30, 2024, Neogen Chemicals reported total income of ₹194.15 crore, up from ₹163.60 crore in the same quarter last year. Revenue from operations was ₹193.36 crore. Net profit for the quarter was ₹10.96 crore, reflecting a slight increase from ₹7.92 crore year-over-year. Earnings per share stood at ₹4.15*.

**Strategic Initiatives and Growth Drivers:**

The company has recently incorporated a wholly-owned subsidiary in Japan, aimed at strengthening ties with Japanese chemical companies. This strategic move is expected to enhance Neogen's market reach and operational capabilities.

**Business Developments:**

Neogen continues its process to amalgamate Buli Chemicals India Private Limited, with the scheme currently awaiting approval from regulatory authorities. The expected synergies from this merger aim to streamline operations and expand the company's portfolio.

**Market Position and Competitive Advantage:**

Neogen maintains a solid position in the specialty chemicals market. The company's continued investments and strategic partnerships position it well to capitalize on emerging opportunities.

**Investor Implications:**

With a positive outlook bolstered by strong quarterly performance and strategic initiatives, investors may see potential growth. However, they should monitor developments related to the amalgamation and market conditions closely.